From Trauma to Transformation: Tania De Jong's Mission to Revolutionize Mental Health

What does it take to change an entire country's approach to mental healthcare? In this episode of The Psychedelic Report, Dr. Dave Rabin sits down with entrepreneur, singer, and Mind Medicine Australia co-founder Tania De Jong to explore how Australia became the first country to federally reschedule MDMA and psilocybin for clinical use in psychiatry. Tania shares her deeply personal journey into psychedelic medicine, inspired by her family's Holocaust history, her own healing experiences, and a mission to make transformative therapies accessible to people living with treatment-resistant mental illness. Together, Dave and Tania discuss the science behind psychedelic-assisted therapy, why clinician training and integration are just as important as the medicines themselves, and the lessons the rest of the world can learn from Australia's groundbreaking model. They also examine the global mental health crisis, the promise of psychedelic medicine for trauma and depression, and what it will take to bring these treatments safely to more people. If you're curious about the future of mental healthcare, this conversation offers an inside look at one of the most significant shifts happening in medicine today. Web: https://www.medicinesaustralia.com.au/ Instagram: https://www.instagram.com/taniadejongam Web: https://thepsychedelic.report Instagram: https://www.instagram.com/drdavidrabin X: https://twitter.com/DrDavidRabin More from Dr. Dave: https://www.drdave.io/ Learn more about your ad choices. Visit megaphone.fm/adchoices